Astronics (ATRO) Q4 2025 earnings review

Aerospace Engine Roars, Masking Test Segment Stagnation

Astronics delivered a blowout Q4, breaking records with a 15% YoY revenue surge and swinging to a $29.6 million net profit. The story here is entirely driven by the Aerospace segment, which saw margins expand massively on soaring commercial and military demand. While management celebrated the Test Systems segment finally eking out a small profit, top-line growth there remains virtually flat as a highly anticipated Army contract was delayed yet again. Guidance for 2026 implies double-digit revenue growth, but investors must monitor heavy upcoming cash outflows for CapEx and a new ERP system.

🐂 Bull Case

Aerospace Margins Exploding

Volume leverage, pricing actions, and a favorable VVIP product mix pushed Aerospace operating margins to 19.0% (19.8% adjusted), proving the company's operating leverage model works at scale.

Record Backlog De-risks 2026

Astronics ended the year with an all-time record backlog of $674.5 million, with 79% expected to be recognized over the next 12 months, providing massive visibility into 2026.

🐻 Bear Case

Cash Flow Squeeze Approaching

Despite strong operational profits, 2026 free cash flow will be pressured by an unusually high $40-$50 million CapEx burden and a newly announced $14-$18 million cash outflow for a global ERP implementation.

Test Segment Timeline Slippage

The long-awaited U.S. Army radio test program production start has slipped again. Originally expected in Q4 2025, it is now targeted for 'early in the second quarter' of 2026.

⚖️ Verdict: 🟢

Bullish. The sheer profitability and momentum of the core Aerospace business easily overshadows the delays in the Test segment. If the Test business finally ramps in mid-2026, there is still upside to the current baseline.

Key Themes

DRIVER🟢🟢

Aerospace Operating Leverage Taking Hold

The Aerospace segment is accelerating beautifully. Volume growth, combined with aggressive pricing actions and the integration of Bühler Motor Aviation (BMA), drove a massive 450 basis point expansion in adjusted operating margins. The segment is now clearing a 19.8% adjusted operating margin—surpassing management's near-term targets and validating the bullish thesis on OEM build rate recovery.

DRIVER🟢

Commercial Transport & Retrofit Boom

Airlines are spending heavily to keep up with consumer electronics life cycles. Commercial Transport sales grew 18.5% YoY, driven primarily by demand for in-flight entertainment and connectivity (IFEC) and cabin power systems. The recent BMA acquisition perfectly positions Astronics to capture more of the seat actuation market within these cabin upgrades.

DRIVERNEW🟢

Debt Refinancing Immediately Accretive

Management's complex Q3 refinancing—swapping expensive 5.5% convertible notes for 0% bonds—is already paying dividends. Interest expense dropped 18.5% YoY in Q4, contributing directly to the bottom line and providing cleaner earnings translation as operating profits scale.

CONCERN🔴

Test Segment Narrative vs. Reality

Management praised the Test segment's return to profitability, but the data tells a contradictory story: sales grew a mere 2.4% YoY to $20.5 million, keeping the segment fundamentally stagnant. More importantly, the critical U.S. Army radio test program (4549/T)—the stated catalyst for the segment's recovery—has slipped yet again from Q4 2025 to 'early in the second quarter' of 2026. The segment's turnaround is entirely dependent on this binary, delayed event.

CONCERNNEW🔴

Heavy 2026 Capital and ERP Burden

While operating cash flow was a healthy $74.8 million in 2025, 2026 cash generation will be severely hobbled. Management guided for $40-$50 million in CapEx (driven by Seattle facility consolidation) and announced a new $14-$18 million cash outflow to implement a global ERP system. This combined $54-$68 million cash drain limits flexibility for buybacks or further aggressive debt reduction in the near term.

CONCERN

Tariff Costs Quietly Eroding Margins

The macro tariff reality is starting to bite. Q4 saw a $2.9 million direct increase in tariff expenses. While this was completely masked by the massive volume and pricing leverage in Aerospace this quarter, it represents a structural cost headwind going into 2026 that management will have to continually chase with price hikes.

Other KPIs

Backlog$674.5 million

Accelerating to an all-time company record, up from $646.7 million at the end of Q3. The Aerospace segment accounted for $600.8 million of this total, rising 11.8% YoY.

Adjusted EBITDA$45.7 million

Accelerating significantly. Margin expanded 390 basis points YoY to 19.0% of sales. Full-year Adjusted EBITDA grew 39.5% to $134.5 million.

Guidance

2026 Full Year Revenue$950 to $990 million

Accelerating. The midpoint of $970 million implies 12.5% YoY growth, a clear step up from the 8.4% growth achieved in 2025. Approximately 79% of the current backlog is slated to convert to revenue over the next 12 months, highly derisking this target.

2026 Q1 Revenue$220 to $230 million

Stable. The $225 million midpoint implies 9.3% YoY growth. This represents a slight deceleration from Q4's 15.1% growth rate, but is historically strong for Q1 seasonality.

Key Questions

Army Test Contract Slippage

The 4549/T Army Radio test program production start has slipped repeatedly and is now targeted for early Q2 2026. What specific milestones remain out of your control, and is any of the $950-$990M revenue guidance at risk if this slides into the second half of the year?

ERP Implementation Risks

You are embarking on a $14-$18M global ERP implementation in 2026. Given the historical disruption ERP migrations cause to manufacturing operations, what specific steps are being taken to isolate the Aerospace segment's momentum from potential system integration issues?

Tariff Mitigation Progress

With $2.9M in tariff expenses recognized in Q4, are current pricing actions fully offsetting this drag, or are you still structurally absorbing a portion of these costs?

Test Segment Strategic Value

With Aerospace margins approaching 20% and the Test segment hovering near breakeven while consuming management attention, what is the strategic threshold or timeline required for the Test segment to prove it belongs in the long-term portfolio?